Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
TME-SW
01698
5
BABA-W
09988
No Data
BTIG Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $5
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), Akebia Therapeutics (AKBA) and Ionis Pharmaceuticals (IONS)
BTIG Reiterates Buy on Akebia Therapeutics, Maintains $5 Price Target
Akebia Therapeutics Analyst Ratings
H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $6
Strategic Expansion and Market Potential Drive Buy Rating for Akebia Therapeutics